[Treatment of XXXX : changes in diagnosis and therapy].

@entity1 @entity175 @entity3549 @entity1911 @entity5 @entity260 @entity3508 @entity2922 @entity1943
Evident progress has been made in the treatment of @entity1911 . The results of hormone analysis became very accurate, the method for @entity5 localisation are non invasive and safe: with 131-I-MIBG, ultrasonography and CT-scan an exact preoperative localisation is possible without serious risks. @entity1 are prepared for the operation with alpha- and beta-blocking agents. Modern methods of anaesthesia with continuous monitoring of blood pressure, pulmonary pressure and cardiac output and a standardized operative procedure are essential. From 1965 to 1987 71 @entity1 with a total of 87 @entity2922 producing @entity5 have been operated. In all cases a transabdominal access was chosen. @entity5 were removed in 8 @entity1 , multiple (7) @entity5 in 2 @entity1 . The comparison of the 2 time intervals 1965 to 1976 and 1977 to 1987 showed a significant decrease of serious intra- and @entity260 . Surgical specimens of 36 @entity1 with @entity1911 were used for immunohistologic evaluation. Marked positivity was found in 44% of cases for @entity175 . The reaction for @entity3549 ( @entity3549 ) was positive in 28% of cases. @entity1943 was not detected in any case, @entity3508 ( @entity3508 ) in all cases. 6 @entity1 with @entity5 were treated with high doses of 131-I-MIBG, 4 other @entity1 received a combined chemotherapy.
